Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)
United States116 participantsStarted 2019-03-01
Plain-language summary
Shoulder pain accounts for 16% of all musculoskeletal complaints in the healthy adult population. Subacromial impingement syndrome (SIS) is the most common cause of shoulder pain. Many patients with chronic pain from subacromial impingement syndrome (SIS) will fail treatment efforts and have longstanding pain. This project will evaluate the efficacy of a novel approach to treatment, percutaneous peripheral nerve stimulation, for participants with chronic shoulder pain due to subacromial impingement syndrome (SIS).
Who can participate
Age range21 Years – 100 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Shoulder pain of \>3 months
✓. Age\>=21
✓. Worst pain in the last week\>=4 (0-10 scale)
✓. Ability to check skin and perform dressing changes, independently or with assistance
✓. Stable dose of pain medication (Not taking more than than 1 opioid or 1 non-opioid analgesic)
Exclusion criteria
✕. Current shoulder joint or overlying skin infection, or current bacterial infection requiring antibiotics
✕. Other chronic pain syndrome (Pain in another area of the body 15 or more days in the last 30 (more than half of the time) or taking daily analgesics for another pain syndrome)
✕. Prior shoulder surgery to ipsilateral shoulder joint (glenohumeral, rotator cuff, acromioclavicular (AC) Joint, etc.)
✕. Corticosteroid injection in the ipsilateral shoulder or any other pain relieving treatment in last 12 weeks
What they're measuring
1
Change in - Short Form (SF) Question 3 (BPI-SF3)
Timeframe: Prior 7-days] ; Baseline (week 1), End of Treatment(week 9), 12 weeks post treatment, 24 weeks post treatment